Skip to main content

Table 1 Analysis of the activity of the pathways by means of different approaches in the case-control comparison of early onset colorectal cancer

From: Understanding disease mechanisms with models of signaling pathway activities

 

Circuits

SEA

  

PATHWAY

Total

Case

Control

UP vs DOWN

UP vs ALL

DOWN vs ALL

GSEA

SPIA

PPAR SIGNALING PATHWAY

106

3

19

DOWN

ALL

ALL

DOWN*

INH*

ERBB SIGNALING PATHWAY

139

11

2

UP

UP

DOWN

DOWN*

INH

CALCIUM SIGNALING PATHWAY

20

2

2

DOWN

UP

DOWN

UP*

ACT

NEUROACTIVE LIGAND-RECEPTOR INTERACTION

7

0

0

UP

UP

ALL

UP*

ACT

APOPTOSIS

28

0

0

DOWN

ALL

DOWN

DOWN*

INH

WNT SIGNALING PATHWAY

37

6

6

UP

UP

DOWN

DOWN*

INH

NOTCH SIGNALING PATHWAY

14

0

0

DOWN

ALL

ALL

DOWN

INH

VEGF SIGNALING PATHWAY

10

2

0

DOWN

ALL

ALL

DOWN

INH

CELL ADHESION MOLECULES

43

6

3

UP

UP

ALL

UP*

- 1

GAP JUNCTION

17

4

0

UP

UP

ALL

UP*

ACT

ANTIGEN PROCESSING AND PRESENTATION

6

0

0

DOWN

ALL

DOWN

UP

ACT

TOLL-LIKE RECEPTOR SIGNALING PATHWAY

103

0

0

UP

UP

DOWN

UP*

INH

JAK-STAT SIGNALING PATHWAY

7

7

0

DOWN

ALL

DOWN

UP*

INH

B CELL RECEPTOR SIGNALING PATHWAY

10

0

0

UP

UP

ALL

UP*

INH

Fc EPSILON RI SIGNALING PATHWAY

7

0

0

UP

ALL

ALL

DOWN*

INH

INSULIN SIGNALING PATHWAY

54

1

0

DOWN

UP

ALL

DOWN*

INH

GnRH SIGNALING PATHWAY

9

0

0

UP

UP

ALL

DOWN*

ACT

MELANOGENESIS

8

1

0

UP

ALL

ALL

UP

ACT

ADIPOCYTOKINE SIGNALING PATHWAY

31

0

2

DOWN

ALL

ALL

UP

INH

  1. 1 - This pathway is not implemented in SPIA.
  2. The first column contains the name of the pathway. The next three columns, collectively labeled as circuits, list the number of sub-pathways in the pathways (Total) and the number of them significantly activated in cases with respect to controls (Case) or vice versa (Control) in the comparison, respectively. The three next columns, collectively labeled as SEA, list the results of a conventional functional enrichment test [3] in three situations: UP vs DOWN) when the significantly upregulated genes are compared to the significantly downregulated genes, UP vs ALL) when significantly upregulated genes are compared to rest of genes, and DOWN vs ALL) when significantly downregulated genes are compared to the rest of genes. UP, DOWN and ALL means where the major part of the pathway lies in the comparison. Significantly up- and downregulated genes are obtained by a conventional t-test with multiple test adjustment as implemented in the Babelomics program [89]. Although the trends of the results are coincident with the other analyses, none of them resulted significant. The column labeled GSEA contains a version of GSEA test [15] implemented in the Babelomics program. The * and the boldface indicate the trend is significant according to the test. The last column, labeled as SPIA, contains the result of the application of the pathway impact analysis [23].